Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.210
+0.040 (3.42%)
At close: Oct 9, 2026, 4:00 PM EDT
1.200
-0.010 (-0.83%)
After-hours: Oct 9, 2026, 7:45 PM EDT
Annovis Bio Employees
Annovis Bio had 7 employees as of December 31, 2025. The number of employees decreased by 8 or -53.33% compared to the previous year. That makes Annovis Bio the 40,858th largest employer in the world and 6,259th in the United States.
Employees
7
Change (1Y)
-8
Growth (1Y)
-53.33%
Revenue / Employee
n/a
Profits / Employee
-$7,074,895
Market Cap
51.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 7 | -8 | -53.33% | 7 | 0 |
| Dec 31, 2024 | 15 | -1 | -6.25% | 8 | 7 |
| Dec 31, 2023 | 16 | 11 | 220.00% | 6 | 10 |
| Dec 31, 2022 | 5 | 2 | 66.67% | 5 | 0 |
| Dec 31, 2021 | 3 | 1 | 50.00% | 3 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Caribou Biosciences | 97 |
| Connect Biopharma Holdings | 64 |
| Elicio Therapeutics | 33 |
| eXoZymes | 32 |
| INmune Bio | 21 |
| LeonaBio | 19 |
| Serina Therapeutics | 16 |
ANVS News
- 2 days ago - Annovis Bio Proxy statement: Proxy filing - Filings
- 16 days ago - Annovis Bio announces partnership with Weave Bio - TheFly
- 16 days ago - Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer's Disease - GlobeNewsWire
- 4 weeks ago - Annovis Bio Proxy statement: Proxy filing - Filings
- 5 weeks ago - Annovis Bio Transcript: Investor update - Transcripts
- 6 weeks ago - Annovis Bio price target lowered to $7 from $8 at Roth Capital - TheFly
- 6 weeks ago - Annovis to Host Corporate Update Webinar on September 2, 2026 - GlobeNewsWire
- 6 weeks ago - Annovis Bio Proxy statement: Proxy filing - Filings